Low Catalytic Redox Activity of α-N-Pyridylthiosemicarbazone Iron Complexes Suggests an Indirect ROS Generation Mechanism in Their Biological Activity.

α-N-Pyridylthiosemicarbazones (PTSC) are anticancer agents that can induce oxidative stress in cells, likely through interactions with metal ions. Redox-active Cu and Fe bind strongly to PTSC, forming complexes Cu-PTSC and Fe-PTSC2. These complexes have been proposed to directly catalyze the formation of reactive oxygen species (ROS) and deplete key cellular reductants, thereby exerting oxidative stress. Alternatively, oxidative stress could also arise indirectly through interactions with other cellular targets. Evaluating catalytic rates could help distinguish direct from indirect mechanisms, as ROS production should outpace antioxidant defenses. In this respect, the catalytic activity of the Fe complexes of two PTSCs, Triapine (3AP) and Dp44mT, with the two most abundant reducing agents, ascorbate and glutathione, was evaluated under aerobic conditions. Fe-3AP2 and Fe-Dp44mT2 showed very low catalytic activity in depleting GSH/ascorbate and producing ROS (<4 turnovers per hour). Higher activity appeared with H2O2 and ascorbate, but only for 1:1 Fe-PTSC complexes, not 1:2 Fe-PTSC2. Competition assays with H2O2-degrading enzyme catalase revealed that Fe-PTSC reacted 3 orders of magnitude slower than the enzyme. Thus, Fe-PTSC and Fe-PTSC2 are unlikely to drive ROS production through a direct mechanism. Instead, an indirect mechanism or a site-specific ROS production appears to be more plausible.

• Publication year

  2025

• Venue

  Inorganic Chemistry

• Publication date

  2025-10-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.inorgchem.5c03520PMID 41039730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiosemicarbazone-Based Compounds: Cancer Cell Inhibitors with Antioxidant Properties

  2025cited by this paper
• Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment

  2024cited by this paper
• Applications of radiocomplexes with thiosemicarbazones and bis(thiosemicarbazones) in diagnostic and therapeutic nuclear medicine

  2022cited by this paper
• Copper-Catalyzed Glutathione Oxidation is Accelerated by the Anticancer Thiosemicarbazone Dp44mT and Further Boosted at Lower pH

  2022cited by this paper
• Antifungal activity of thiosemicarbazones, bis(thiosemicarbazones), and their metal complexes.

  2021cited by this paper
• High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones

  2020cited by this paper
• In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target.

  2020cited by this paper
• Exploiting Cancer Metal Metabolism using Anti-Cancer Metal- Binding Agents.

  2019cited by this paper
• Ironing out the role of the cyclin‐dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

  2019cited by this paper
• Proton-assisted air oxidation mechanisms of iron(ii) bis-thiosemicarbazone complexes at physiological pH: a kinetico-mechanistic study.

  2019cited by this paper
• Concentration of Fe(3+)-Triapine in BEAS-2B Cells

  2019cited by this paper
• Reactivity of Cu(ii)-, Zn(ii)- and Fe(ii)-thiosemicarbazone complexes with glutathione and metallothionein: from stability to dissociation to transmetallation.

  2019cited by this paper
• Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development

  2018cited by this paper
• Revisiting the thiosemicarbazonecopper(II) reaction with glutathione. Activity against colorectal carcinoma cell lines.

  2018cited by this paper
• Piperidylthiosemicarbazones Cu(II) complexes with a high anticancer activity by catalyzing hydrogen peroxide to degrade DNA and promote apoptosis.

  2018cited by this paper
• The role of oxidative stress in activity of anticancer thiosemicarbazones

  2018cited by this paper
• Glutathione limits aquacopper(I) to sub-femtomolar concentrations through cooperative assembly of a tetranuclear cluster

  2017cited by this paper
• Biological Production, Detection, and Fate of Hydrogen Peroxide

  2017cited by this paper
• Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment

  2017cited by this paper
• Lysosomal membrane stability plays a major role in the cytotoxic activity of the anti-proliferative agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT).

  2016cited by this paper
• Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics.

  2016cited by this paper
• The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms

  2016cited by this paper
• Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics.

  2016cited by this paper
• Even free radicals should follow some rules: a guide to free radical research terminology and methodology.

  2015cited by this paper
• Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator.

  2014cited by this paper
• Mechanistic Studies of Semicarbazone Triapine Targeting Human Ribonucleotide Reductase in Vitro and in Mammalian Cells

  2012cited by this paper
• Interaction of Triapine and related thiosemicarbazones with iron(III)/(II) and gallium(III): a comparative solution equilibrium study.

  2011cited by this paper
• Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds

  2011cited by this paper
• The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR study.

  2010cited by this paper
• Comparative Solution Equilibrium Study of the Interactions of Copper(II), Iron(II) and Zinc(II) with Triapine (3‐Aminopyridine‐2‐carbaldehyde Thiosemicarbazone) and Related Ligands

  2010cited by this paper
• The iron chelator Dp44mT does not protect myocytes against doxorubicin.

  2009cited by this paper
• Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.

  2009cited by this paper
• A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase

  2006cited by this paper
• Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity.

  2006cited by this paper
• Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple.

  2001cited by this paper
• Hydrogen peroxide in the human body

  2000cited by this paper
• Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity.

  1999cited by this paper
• Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide.

  1999cited by this paper
• Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress.

  1992cited by this paper
• Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.

  1989cited by this paper
• Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid)--a reexamination.

  1979cited by this paper
• Tissue sulfhydryl groups.

  1959cited by this paper

• No citing papers are available for this paper.